Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

NMDAR Modulation As a Therapeutic Target and Probe of Neural Dysfunction in OCD

To see complete record on, please visit this link

Id: NCT02624596

Organisation Name: Stanford University

Overal Status: Active, not recruiting

Start Date: June 2016

Last Update: May 26, 2022

Lead Sponsor: Stanford University

Brief Summary: The purpose of this study is to understand how ketamine brings about rapid improvement in Obsessive-Compulsive Disorder (OCD) symptoms.

  • Obsessive-Compulsive Disorder

Total execution time in seconds: 0.19927215576172